Risk prediction of atrial fibrillation and its complications in the community using hs troponin I

• DOI: 10.1111/eci.13950
• Publication Date: 2023-01-05T15:26:10Z
• Authors: Christin S. Börschel; Bastiaan Geelhoed; Teemu Niiranen; Stephan Camen; Maria Benedetta D...; Aki S. Havulinna; Francesco Gianfagna; Tarja Palosaari; Pekka Jousilahti; Jukka Kontto; Erkki Vartiainen; Francisco M. Ojeda; Hester M. den Rui...; Simona Costanzo; Giovanni de Gaetano; Augusto Di Castel...; Allan Linneberg; Julie K. Vishram‐...; Maja‐Lisa Løchen; Wolfgang Koenig; Torben Jørgensen; Kari Kuulasmaa; Stefan Blankenberg; Licia Iacoviello; Tanja Zeller; Stefan Söderberg; Veikko Salomaa; Renate B. Schnabel
• Keywords: Rotterdam Study

Atrial fibrillation (AF) is becoming increasingly common. Traditional cardiovascular risk factors (CVRF) do not explain all AF cases. Blood-based biomarkers reflecting cardiac injury such as high-sensitivity troponin I (hsTnI) may help close this gap.